The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) focuses on advancing the science and understanding of CLL and lymphoproliferative disorders.
iwCLL is officially underway!
Whether you're here with us in Kraków or participating from home, we'd love to see your experience. Share your photos, insights, and key takeaways using #iwCLL2025.
⏳ Last call to register for #iwCLL2025! ⏳
✅ Cutting-edge research insights
✅ Practical patient care discussions
✅ Unmatched networking opportunities
Virtual registration is available! Secure your spot TODAY: https://t.co/Ds1v2ntsjE
#FlashbackFriday: Dr. Andrew Lipsky represents the new wave of investigators shaping CLL research.
Join this generation in Kraków at the Young Investigators Meeting:https://t.co/Ds1v2ntsjE
#iwCLL2025#CLL
🚨 Just 1 week to go! 🚨
#iwCLL2025 is almost here!
❇️Explore the latest breakthroughs in #CLL research
❇️Discuss practical strategies for patient care
❇️Connect with global experts in the field
Register now: https://t.co/Ds1v2ntsjE
Workshop 3 will summarize new technologies in #CLL diagnostics and monitoring response to therapy. MRD-guided therapy is an important issue for the future landscape of CLL treatment
Register today: https://t.co/Ds1v2ntsjE
We have 3 concurrent workshop breakout sessions to truly tailor your experience at #iwCLL2025.
Workshop 1 will focus on case studies of rare symptoms and complications in #CLL.
Workshop 2 will focus on adaptive trial designs for testing novel agents for #CLL.
#FlashbackFriday: Prof. Michael Hallek on why collaboration drives progress in #CLL.
Let’s continue the conversation in Kraków. https://t.co/Ds1v2ntsjE
#iwCLL2025
#iwCLL2025 in Kraków, Poland, is a few weeks away!
Engage with cutting-edge insights, collaborate to advance patient management, and foster connections that fuel progress in the field.
Sign up today: https://t.co/Ds1v2ntsjE
Join global leaders in the #CLL at #iwCLL2025 in Kraków, Poland (12–15 September 2025).
Experience innovations in research and discuss strategies to transform CLL patient care. Network to elevate the standard of practice.
Register: https://t.co/Ds1v2ntsjE
Are you under 40 and driven to shape the future of #CLL research?
The #YoungInvestigator Meeting—held ahead of #iwCLL2025—is your chance to connect with experts, share groundbreaking ideas, and collaborate in a relaxed environment.
Register Now: https://t.co/Ds1v2ntsjE
Explore the Future of #CLL Care at #iwCLL2025
Join us 12–15 September 2025 in Kraków, Poland!
Gain insights into breakthrough research, exchange ideas on patient management, and connect with top minds in the field of #CLL.
Secure your spot now: https://t.co/Ds1v2ntsjE
🚨 Submission Deadline: 05 August 2025 🚨
The iwCLL committee invites original papers that delve into scientific questions, showcase new research, or present groundbreaking results related to treating patients with #CLL.
📖 More information: https://t.co/1r26D7bcEE
•Patient comorbidities and their impact on therapy
Register to hear important topics that will improve your patients’ well-being: https://t.co/Ds1v2ntsjE
#iwcll2025#PatientOutcomes
How do you help maintain the optimal health of patients with #CLL undergoing therapy?
Topics that will be discussed include:
•Vaccination and infection issues in patients that are immunocompromised
•Balancing comedications throughout treatment
The iwCLL committee invites original papers on #CLL, featuring new research, scientific discoveries, or advancements in patient care.
Submission deadline: 05 Aug 2025.
Share your work with the global CLL community!
Learn more: https://t.co/1r26D7bcEE
#iwCLL2025
Join us in Kraków, Poland on 12–15 September 2025 for #iwCLL2025.
Attendees will learn about cutting-edge research in #CLL and debate the practical management of patients with CLL, all while networking to advance the field of CLL.
Register today: https://t.co/Ds1v2ntsjE
Learn more about #iwCLL2025 at booth 17147 during #ASCO25!
Not in Chicago? Visit https://t.co/rtg10FRBL7 to explore how #iwCLL2025 will examine cutting-edge #CLL research, updated strategies on patient management, and novel therapies advancing the field of CLL.